Can tumour marker assays be a guide in the prescription of bone scan for breast and lung cancers?

Considering the current need to improve cost-effectiveness in cancer patient management, a prospective study was undertaken in order to define the optimal combination of bone scan and tumour marker assays in breast and lung cancer strategies, as has been done in the case of prostate cancer. All patients with breast or lung cancer referred to the Nuclear Medicine Department of the Grenoble Teaching Hospital between December 1995 and April 1997 were included. A blood sample was drawn in each case for marker assay (CA15-3 or CEA and CYFRA 21-1) on the same day as the bone scan. Two hundred and seventy-five patients were included: 118 with lung cancer and 157 with breast cancer. With regard to lung cancer, no information useful for guiding bone scan prescription was obtained through CEA and CYFRA 21-1 assays. For breast cancer, the results suggest that in asymptomatic patients, a CA15-3 level of less than 25 U/ml (upper normal value chosen as the threshold) is strongly predictive of a negative bone scan; by contrast, high tumour marker levels are predictive of neoplastic bone involvement. When a doubtful bone scan is obtained in a patient with breast cancer, a normal marker level makes it highly probable that bone scan abnormalities are not related to malignancy.

Acute pulmonary embolism: role of helical CT in 164 patients with intermediate probability at ventilation-perfusion scintigraphy and normal results at duplex US of the legs.

PURPOSE: To assess prospectively the clinical effectiveness of helical computed tomography (CT) in the evaluation of patients with unresolved suspicion for pulmonary embolism (PE). MATERIALS AND METHODS: Helical CT was performed in 164 consecutive patients suspected of having acute PE, intermediate probability at ventilation-perfusion (V-P) scintigraphy, and normal findings at duplex ultrasonography (US) of the legs. Fifteen patients also underwent pulmonary angiography. Helical CT results were analyzed immediately to help plan anticoagulant treatment. If helical CT did not show PE, anticoagulant treatment was not indicated. Clinical outcome for these patients was assessed during 3-month follow-up. RESULTS: In 40 (24.4%) of 164 patients, the diagnosis of PE was based on results at helical CT (n = 39) or pulmonary angiography (n = 1). Repeated Doppler US of the legs depicted one thrombus in the calf of three patients with normal results at helical CT that could have been responsible for PE. During 3-month follow-up, three patients experienced recurrent PE (one death, two recurrences). Therefore, PE occurred in six (5.4% [95% confidence interval, 1.3%, 9.7%]) of 112 patients with normal findings at helical CT who did not receive anticoagulant treatment. CONCLUSION: Findings at helical CT allowed accurate diagnosis of acute PE in patients with intermediate probability at V-P scintigraphy and without deep venous thrombosis at duplex sonography of the legs.

Pulmonary embolus as a complication of femoral venous catheter removal.

The case of a 31 year old woman who developed asymptomatic pulmonary emboli after removal of a femoral venous catheter is reported. A deep venous thrombus had previously been shown to be associated with the catheter. Therefore it is argued that care should be taken when removing femoral lines especially in patients at high risk of thrombosis and that femoral venous duplex scan may be warranted prior to line removal in these high risk patients.

[Value and limitations of pulmonary scintigraphy/venous duplex Doppler echography in the management of pulmonary embolism]. / Intérêts et limites du couple scintigraphie pulmonaire/écho-Doppler veineux dans la gestion de l'embolie pulmonaire.

PURPOSE: To assess the accuracy of diagnostic strategy of pulmonary embolism (PE) based on clinical examination, lung scan and venous duplex US findings. METHODS: 1,819 patients have been included in a prospective study (mean age: 66, range: 6-102, F 54% H 46%) over a 13 month period. RESULTS: To decide the opportunity of anticoagulant therapy, lung scan alone is decisive in 30.6% of the cases. When taking into account clinical examination, lung scan and venous duplex US findings in a combined diagnostic strategy, a therapeutic decision can be made for 74.2% of the patients. The decisive characteristics of this strategy were influenced by two factor: age (therapeutic decision can be reached for 83% of the patients aged 30 to 50 vs 65% when they are over 85, p < 0.01); history of heart or pulmonary disease (therapeutic decision reached in 62% of the cases with history vs 78% without, p < 0.01). CONCLUSION: Pulmonary angiography seems theoretically necessary in less than 26% of the patients with suspected PE when they have undergone lung scan and venous duplex US. In this case, and when these strategies are not very decisive, it would be important to assess the diagnostic value of spiral CT scanning.

[Evaluation of the diagnostic usefulness of CA125 immunoscintigraphy for ovarian carcinoma follow-up after treatment: contribution of this technique in Grenoble University Medical Center]. / Evaluation de l'utilité diagnostique de l'immunoscintigraphie au CA.125 dans le suivi des carcinomes du revêtement épithélial de l'ovaire après traitement: apport décisionnel de la technique au CHU de Grenoble.

Immunoscintigraphy using indium-111-labeled OC125 monoclonal antibody F(ab')2 fragments is a technic complementary of morphological imaging (i.e. ultrasonography and computed tomography). It allows early detection of recurrences of ovarian carcinomas. We performed immunoscintigraphy 30 times in 26 patients who previously underwent radical treatment for ovarian carcinoma, and were suspected to have a recurrence. Our purposes were appreciation of diagnostic accuracy of the method, and above all its impact on clinical decisions and evolution of the patients. There were, after reevaluation of the results, 18 true positives, 7 true negatives, 3 false negatives and 2 false positive cases (sensitivity 85.7%, specificity 77.8%). Bayesian analysis showed positive and negative predictive values of 86% and 87% when probability of recurrence a priori was 50%, and 80% and 58% when probability of recurrence a priori was 70%. The result of immunoscintigraphy contributed to clinical decisions in 24 cases out of 30, and led to a correct decision for the patient in 21 cases. Conversely, for the 6 cases in which the result has not been considered, to take this result into account would have been beneficial in 4 cases, but harmful in 2. Finally, survival tended to be longer when immunoscintigraphy was negative, which could be associated with a better prognosis. We conclude that OC125-immunoscintigraphy may be useful for ovarian carcinoma follow-up and may contribute to a better therapeutic strategy.

[Pulmonary scintigraphy in the diagnosis of pulmonary embolism]. / La scintigraphie pulmonaire dans le diagnostic d'embolie pulmonaire.

Venous thromboembolism (VTE) and pulmonary (PE) are difficult to diagnose. Pulmonary scintigraphy is a key investigation in the diagnosis of PE due to its innocuity and high sensitivity. A complete examination requires analysis of ventilation and perfusion (with at least four different views). The sensitivity of the method is excellent and a normal perfusion pulmonary scintigraphy excludes the diagnosis (10-15% of cases). On the other hand, the specificity is not nearly as good as only 10 to 15% of scintigraphies show changes which make the diagnosis of PE certain. In about 2 out of 3 cases, pulmonary scintigraphy alone is not decisional and only allows an estimation of the probability of PE this investigation must be integrated in the diagnostic strategy based on the "a priori" clinical probability, non invasive venous exploration and, in second intention, pulmonary angiography. The authors report the diagnostic strategy defined in Grenoble University hospital after multidisciplinary concertration. An evaluation in 103 patients with suspected PE showed a divergence from this diagnostic protocol in 38% of cases. However, when the protocol is respected, a therapeutic decision can be taken in 73% of cases based on clinical assessment scintigraphy and Doppler ultrasonography. Therefore, the diffusion and observance of these diagnostic strategies should be improved. In these conditions, pulmonary scintigraphy plays an essential role in the diagnosis of PE. The necessity of a control pulmonary scintigraphy and the value of systematic scintigraphy in the presence of proximal venous thrombosis are also discussed.